Home > Boards > US Listed > Biotechs > Celsion Corporation (CLSN)

14:39:0512-11-2012 14:02 *DJ Celsion 3Q Research And

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
zendeli Member Profile
 
Followed By 0
Posts 118
Boards Moderated 0
Alias Born 04/28/10
160x600 placeholder
Celsion Corporation Invited to Present Poster at Cytokine-Based Cancer Immunotherapies Summit GlobeNewswire Inc. - 11/29/2021 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 9:05:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 8:47:30 AM
Celsion EPS beats by $0.03, beats on revenue Seeking Alpha - 11/15/2021 8:37:20 AM
Celsion Corporation Reports Third Quarter 2021 Financial Results and Provides Business Update GlobeNewswire Inc. - 11/15/2021 8:30:00 AM
Celsion Corporation to Hold Third Quarter 2021 Financial Results and Business Update Conference Call on Monday, November 15, 2021 GlobeNewswire Inc. - 11/9/2021 9:00:00 AM
Celsion Provides Update on its Application to Sell $1.5 Million of New Jersey Net Operating Losses GlobeNewswire Inc. - 11/8/2021 9:00:00 AM
Celsion Corporation’s GEN-1 IL-12 Program to be Featured at Cytokine-Based Cancer Immunotherapies Summit GlobeNewswire Inc. - 11/8/2021 8:30:00 AM
Celsion Corporation Announces Time of Oral Presentation at International Vaccines Congress GlobeNewswire Inc. - 10/15/2021 9:00:00 AM
Celsion Corporation Announces Oral Presentation at International Vaccines Congress GlobeNewswire Inc. - 10/12/2021 9:00:00 AM
Celsion GmbH Announces the Publication of an Article Reviewing the History of ThermoDox® Drug Development in Advanced Drug Delivery Reviews GlobeNewswire Inc. - 10/11/2021 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2021 8:51:28 AM
Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities GlobeNewswire Inc. - 10/5/2021 9:00:00 AM
Celsion to Present at Three Investment Conferences in October GlobeNewswire Inc. - 9/30/2021 9:00:00 AM
Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion’s DNA-based Vaccine GlobeNewswire Inc. - 9/17/2021 9:00:00 AM
Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform GlobeNewswire Inc. - 9/2/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2021 8:52:48 AM
Celsion Corporation Reports Second Quarter 2021 Financial Results and Provides Business Update GlobeNewswire Inc. - 8/12/2021 8:00:00 AM
Celsion Corporation to Hold Second Quarter 2021 Financial Results and Business Update Conference Call on Thursday, August 12, 2021 GlobeNewswire Inc. - 8/5/2021 8:00:00 AM
Results of Celsion’s OVATION 1 Study with GEN-1 in Patients with Advanced Ovarian Cancer Published in the Journal of Clinical Cancer Research GlobeNewswire Inc. - 7/29/2021 10:00:00 AM
Celsion drops 4% despite DSMB green light to continue mid-stage ovarian cancer study Seeking Alpha - 7/19/2021 10:08:28 AM
Celsion Reports Data Safety Monitoring Board Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATIO... GlobeNewswire Inc. - 7/19/2021 8:00:00 AM
Celsion Corporation Expands Vaccine Advisory Board with the Addition of Dr. Dan H. Barouch and Dr. Luke D. Handke GlobeNewswire Inc. - 7/15/2021 8:00:00 AM
Celsion GmbH Announces Commencement of Enrollment in Oxford University’s Phase 1 Study with ThermoDox® and Focused Ultraso... GlobeNewswire Inc. - 7/1/2021 8:00:00 AM
Celsion Corporation Establishes Wholly Owned Subsidiary to Manage Investigator-Sponsored Development of ThermoDox® GlobeNewswire Inc. - 6/23/2021 8:00:00 AM
zendeli   Monday, 11/12/12 08:40:21 AM
Re: zendeli post# 4795
Post # of 16739 
14:39:05
12-11-2012 14:02 *DJ Celsion 3Q Research And Development Costs $3.5M >CLSN



(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)

November 12, 2012 08:02 ET (13:02 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences